Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double-blind, placebo-controlled, multicenter parallel group phase III study Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR).

Trial Profile

A randomized, double-blind, placebo-controlled, multicenter parallel group phase III study Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2010

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Atherosclerosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms METEOR
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Oct 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 28 Mar 2007 Results have been published.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top